ACCESS Act
Summary
The ACCESS Act expands STLDI to up to 3 years, exempt from ACA essential health benefits and MLR rules, directly benefiting major health insurers. The bill is early-stage with low legislative momentum. Market data shows UNH +36%, HUM +39%, and CI +9% over 30 days, reflecting anticipatory pricing of regulatory relief.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.ACCESS Act redefines STLDI to allow up to 3-year terms, exempt from ACA essential health benefits and MLR rules
- 2.Bill is early-stage with low momentum: 3 actions, 2 cosponsors, no Senate counterpart
- 3.UNH, CI, and HUM are direct beneficiaries via a new high-margin product category
Market Implications
The 30-day rallies in UNH (+36%), HUM (+39%), and CI (+9%) partially price in regulatory relief expectations, but the ACCESS Act itself faces long odds given minimal congressional action. Near-term, the bill's progress will be a sentiment driver. A committee hearing or markup could trigger additional upside; failure to advance after the midterm election cycle could trigger profit-taking. The structural case for STLDI expansion remains, but timing is uncertain.
Full Analysis
The ACCESS Act (HR 6420) was introduced on December 4, 2025 by Rep. Miller (R-OH) and cosponsored by Rep. Allen (R-GA). The bill has been referred to the House Committee on Energy and Commerce, with only 3 actions recorded — all on the introduction date. This is an early-stage bill with minimal progress. The bill amends the Public Health Service Act to define short-term limited duration insurance as contracts with an initial term under 12 months and total duration (including renewals) of up to 3 years. Critically, STLDI plans are exempt from ACA essential health benefit requirements and medical loss ratio rules, giving insurers higher margin flexibility. No specific funding is authorized or appropriated — the bill changes regulatory definitions, not direct spending. The primary mechanism is regulatory relief: insurers gain a new product category with lower compliance costs. For UnitedHealth Group ($UNH), Cigna ($CI), and Humana ($HUM), this means the ability to sell multi-year premium products with fewer mandated benefits, improving margins per enrollee. Real market data shows substantial recent gains: UNH at $368.13 (30-day +36.05%), CI at $290.85 (+9.03%), and HUM at $241.35 (+39.19%). These moves likely reflect broader market expectations of regulatory relief under the current administration, as the bill itself has stalled since December 2025. The legislative path remains long: committee markup, House floor vote, Senate introduction/passage, and presidential signature. With only 2 cosponsors, momentum is low.
Intelligence Surface
Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures
Multiple independent sources confirm this signal’s market thesis
What the bill does
Expansion of short-term limited duration insurance (STLDI) to up to 3 years, exempt from ACA essential health benefits and MLR rules
Who must act
Health insurance issuers offering STLDI plans
What happens
Creates a new multi-year premium product category with lower regulatory costs, enabling higher margins per enrollee compared to ACA-compliant plans
Stock impact
UnitedHealthcare (UnitedHealth Group's insurance segment) can market STLDI plans to employers and individuals, capturing premium revenue exempt from MLR rebate requirements; estimated potential to shift 5-10% of individual market premium volume to STLDI
What the bill does
Expansion of short-term limited duration insurance (STLDI) to up to 3 years, exempt from ACA essential health benefits and MLR rules
Who must act
Health insurance issuers offering STLDI plans
What happens
Creates a new multi-year premium product category with lower regulatory costs, enabling higher margins per enrollee compared to ACA-compliant plans
Stock impact
Cigna's employer and individual plan segments can offer STLDI products to small businesses and self-employed, generating premium income without ACA benefit mandates; estimated potential to capture 3-8% of Cigna's individual and small group book
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
Association Health Plans Act
Medicare for All Act
Veterans’ ACCESS Act of 2025
To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes.
Protecting Health Care and Lowering Costs Act of 2025
Veteran Caregiver Reeducation, Reemployment, and Retirement Act
To amend title XVIII of the Social Security Act to ensure stability for provider payments under the Medicare program.
TRIWEST HEALTHCARE ALLIANCE CORP: $820M Department of Veterans Affairs Contract
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Implementing Schedule Policy/Career in the Excepted Service
This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.
Realigning United States Core Childhood Vaccine Recommendations with Best Practices from Peer, Developed Countries
This executive order directs the CDC and ACIP to review and potentially update the U.S. childhood vaccine schedule to align with recommendations from peer developed countries, which recommend fewer vaccines. It maintains insurance coverage for all currently available vaccines without cost sharing and emphasizes protecting religious liberty and parental authority.
Promoting Efficiency, Accountability, and Performance in Federal Contracting
This executive order mandates that federal agencies default to using fixed-price contracts for procurement, shifting away from cost-reimbursement models. It requires written justification and senior-level approval for any non-fixed-price contract over certain dollar thresholds (e.g., $10M for most agencies, $100M for the Department of War), and directs agencies to review and renegotiate their 10 largest non-fixed-price contracts within 90 days. The order also tasks OMB with implementation guidance and the Federal Acquisition Regulatory Council with proposing regulatory amendments within 120 days.